The DOI matches its Crossref record, with a small difference in title or year; 40 of the 40 references it cites were found in a registry or an index.
The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis
Abstract
Background: Psychostimulants are frequently prescribed off-label for adults with major depressive disorder or bipolar disorder. The frequent and increasing usage of stimulants in mood disorders warrants a careful appraisal of the efficacy of this class of agents. Herein, we aim to estimate the efficacy of psychostimulants in adults with unipolar or bipolar depression. Methods: The PubMed/Medline database was searched from inception to January 16, 2016 for randomized, placebo-controlled clinical trials investigating the antidepressant efficacy of psychostimulants in the treatment of adults with unipolar or bipolar depression. Results: Psychostimulants were associated with statistically significant improvement in depressive symptoms in major depressive disorder (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.13–1.78; P = 0.003) and bipolar disorder (OR, 1.42; 95% CI, 1.13–1.78; P = 0.003). Efficacy outcomes differed across the psychostimulants evaluated as a function of response rates: ar/modafinil (OR, 1.47; 95% CI, 1.20–1.81; P = 0.0002); dextroamphetamine (OR, 7.11; 95% CI, 1.09–46.44; P = 0.04); lisdexamfetamine dimesylate (OR, 1.21; 95% CI, 0.94–1.56; P = ns); methylphenidate (OR, 1.49; 95% CI, 0.88–2.54; P = ns). Efficacy outcomes also differed between agents used as adjunctive therapy (OR, 1.39; 95% CI, 1.19–1.64) or monotherapy (OR, 2.25; 95% CI, 0.67–7.52). Conclusions: Psychostimulants are insufficiently studied as adjunctive or monotherapy in adults with mood disorders. Most published studies have significant methodological limitations (eg, heterogeneous samples, dependent measures, type/dose of agent). In addition to improvements in methodological factors, a testable hypothesis is that psychostimulants may be more appropriately tested in select domains of psychopathology (eg, cognitive emotional processing), rather than as “broad-spectrum” antidepressants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent systematic reviews support the use of dopaminergic compounds (stimulants and stimulants-like compounds) both for unipolar and bipolar depression (McIntyre et al., 2017; Nunez et al., 2020; Szmulewicz et al., 2017).”
From Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis (2022) · cites this paper as McIntyre et al., 2017
In the citing paper
“The importance of dopaminergic agents in depression has been suggested in both in unipolar and bipolar depression (McIntyre et al., 2017; Nunez et al., 2020; Szmulewicz et al., 2017) showing promising results as augmentation strategies.”
From Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis (2022) · cites this paper as McIntyre et al., 2017
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Funnel plots for detecting bias in meta-analysis
Sterne, J. A. C., & Egger, M. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00377-8 · Cited by 3,779
Nelson, J. C., & Papakostas, G. I. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030312 · Cited by 552
Imputing response rates from means and standard deviations in meta-analyses
Furukawa, T. A., Cipriani, A., Barbui, C., Brambilla, P., & Watanabe, N. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200501000-00010 · Cited by 337
Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv082 · Cited by 315
Self-citationA Placebo-Controlled Evaluation of Adjunctive Modafinil in the Treatment of Bipolar Depression
Frye, M. A., Grunze, H., Suppes, T., McElroy, S. L., Keck, P. E., Walden, J., Leverich, G. S., Altshuler, L. L., Nakelsky, S., Hwang, S., et al. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06060981 · Cited by 249
Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians
Olfson, M., Kroenke, K., Wang, S., & Blanco, C. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08834 · Cited by 221
Fava, M., Thase, M. E., & DeBattista, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0112 · Cited by 207
Lee, H., Kim, S.-W., Kim, J.-M., Shin, I.-S., Yang, S.-J., & Yoon, J.-S. (2005) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.668 · Cited by 206
DeBattista, C., Doghramji, K., Menza, M. A., Rosenthal, M. H., Fieve, R. R., & Modafinil in Depression Study Group (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0911 · Cited by 189
Research works printed but not linked: 1
- 2008, Psychostimulants for depression, Cochrane Database Syst Rev, 2, CD006722
Cited by
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
Crouse, J. J., Carpenter, J. S., Song, Y. J. C., Hockey, S. J., Naismith, S. L., Grunstein, R. R., Scott, E. M., Merikangas, K. R., Scott, J., & Hickie, I. B. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00034-1 · Cited by 255
Nuñez, N. A., Joseph, B., Pahwa, M., Kumar, R., Resendez, M. G., Prokop, L. J., Veldic, M., Seshadri, A., Biernacka, J. M., Frye, M. A., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.134 · Cited by 215
Monoaminergic system and depression
Perez-Caballero, L., Torres-Sanchez, S., Romero-López-Alberca, C., González-Saiz, F., Mico, J. A., & Berrocoso, E. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-2978-8 · Cited by 204
Annual Research Review: Defining and treating pediatric treatment‐resistant depression
Dwyer, J. B., Stringaris, A. K., Brent, D. A., & Bloch, M. H. (2020) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13202 · Cited by 165
Metadata
- Authors
- McIntyre, R. S., Lee, Y., Zhou, A. J., Rosenblat, J. D., Peters, E. M., Lam, R. W., Kennedy, S. H., Rong, C., & Jerrell, J. M.
- Affiliations
- University Health Network (CA)
- University of Saskatchewan (CA)
- University of British Columbia (CA)
- Corresponding author
- McIntyre, Roger S.
- Lee, Yena
- Zhou, Aileen J.
- Rosenblat, Joshua D.
- Kennedy, Sidney H.
- Rong, Carola
- Jerrell, Jeanette M.
- ORCID
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2017-08
- Volume
- 37
- Issue
- 4
- Pages
- 412-418
- ISSN
- 0271-0749 (ISSN-L)
- 1533-712X
- OpenAlex
- W2622834257
- Cited by
- 75
- References
- 40
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 7 · 2021: 13 · 2020: 10 · 2019: 11 · 2018: 7 · 2017: 2
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- psychostimulants, major depressive disorder, bipolar depression, antidepressant efficacy, modafinil, d-amphetamine, lisdexamfetamine, methylphenidate, adjunctive therapy, monotherapy, methodological limitations, mood disorders, adults, response rate, depressive symptoms
- MeSH terms
- Modafinil, Central Nervous System Stimulants, Benzhydryl Compounds, Major Depressive Disorder, Dextroamphetamine, Humans, Methylphenidate, Psychotropic Drugs, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1097/jcp.0000000000000723
- The paper
- McIntyre, R. S., Lee, Y., Zhou, A. J., Rosenblat, J. D., Peters, E. M., Lam, R. W., Kennedy, S. H., Rong, C., & Jerrell, J. M. (2017). The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000000723
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.